Related Experiment Video
Updated: Jul 4, 2025
03:20
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
Published on: September 22, 2023
1.7K
Relationship among Parkinson's disease, constipation, microbes, and microbiological therapy
Xin-Yang Yuan1,2, Yu-Sen Chen1,2, Zhou Liu1,3
1Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, Guangdong Province, China.
World Journal of Gastroenterology
|February 5, 2024
Summary
Altered gut bacteria, particularly increased Proteobacteria and Bacteroidetes, are linked to constipation in Parkinson's disease (PD). Microbiological treatments like probiotics and fecal microbiota transplantation (FMT) show promise for symptom relief.
Area of Science:
- Gastroenterology
- Neurology
- Microbiology
Background:
- Constipation is a common non-motor symptom in Parkinson's disease (PD), significantly impacting patient well-being.
- Gut microbiota alterations, including increased Proteobacteria and Bacteroidetes, are observed in PD-related constipation.
- Current treatments for PD constipation offer limited efficacy, driving the need for novel therapeutic approaches.
Purpose of the Study:
- To review the relationship between gut microbiota and constipation in Parkinson's disease.
- To explore the potential of microbiological interventions for managing PD-related constipation.
Main Methods:
- Comprehensive literature review of studies investigating gut microbiota in Parkinson's disease patients with constipation.
- Analysis of findings on the efficacy of prebiotics, probiotics, and fecal microbiota transplantation (FMT).
Main Results:
- Significant alterations in gut microbiota composition are evident in PD-related constipation.
- Prebiotics improve bowel movements; probiotics enhance stool consistency and reduce discomfort.
- Fecal microbiota transplantation (FMT) demonstrates potential in restoring gut balance and alleviating constipation in PD patients.
Conclusions:
- Microbiota-targeted therapies offer promising avenues for managing Parkinson's disease constipation.
- Further research is essential to establish causality and optimize these interventions for PD patients.
Keywords:
ConstipationFecal microbiota transplantationGut microbiotaParkinson diseasePrebioticsProbioticsMore Related Videos
05:41Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
2.9K
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
1.8K
Related Concept Videos
01:24Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
01:15Parkinson's Disease: Overview
547
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
547
01:21Drugs for Treatment of Constipation-Predominant IBS
169
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
169
01:29Bacterial Flora of the Large Intestine
451
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
451
01:17Irritable Bowel Syndrome I: Introduction
276
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
276
01:17Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450